Prevalence and Factors Associated With Financial Toxicity in Cervical Cancer Patients: A Cross‐Sectional Study
Prävalenz und assoziierte Faktoren von finanzieller Toxizität bei Patient:innen mit Zervixkarzinom: eine Querschnittsstudie
Nursing Open · 2026-10 · 13 (10)
DOI: 10.1002/nop2.70873 ↗Auf einen Blick
Bei 351 Patient:innen mit Zervixkarzinom lag die Prävalenz finanzieller Toxizität bei 66,4 %. Mehrere demografische und klinische Faktoren waren damit assoziiert.
Fragestellung
Wie häufig ist finanzielle Toxizität bei Patient:innen mit Zervixkarzinom, und welche Faktoren sind damit assoziiert?
Methode
Querschnittliche quantitative Studie mit 351 Patient:innen; Erhebung von November 2023 bis November 2024; logistische Regression.
Ergebnisse
Prävalenz 66,4 %. In der multivariablen Analyse war ein höheres Alter pro 1 Jahr, kommerzielle Versicherung und < 3 Hospitalisierungen mit geringerem Risiko assoziiert; niedrigere Ersparnisse, ländlich-städtische Basisversicherung und Radiotherapie mit höherem Risiko.
Schlussfolgerung der Autor:innen
Die Studie identifizierte Faktoren, die mit finanzieller Toxizität bei Patient:innen mit Zervixkarzinom assoziiert sind, und könnte helfen, Hochrisikopatient:innen früh zu erkennen und individuelle Pflegepläne zu entwickeln.
Kernaussagen
- Finanzielle Toxizität: 66,4 % bei 351 Patient:innen
- Niedrigere Ersparnisse und Radiotherapie waren mit höherem Risiko assoziiert
- Alter, Versicherung und Hospitalisierungen waren ebenfalls assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Nursing Open, online erschienen am 30.09.2026. Verfasst von Dongliu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Yan'an University, Yan'an, Shaanxi, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Financial Stress. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yan'an Science and Technology Development, Science and Technology Development Research Project of Affiliated Hospital of Yan'an University, Natural Science Foundation of Shaanxi Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Financial toxicity threatens the survival and prognosis of cervical cancer patients, yet systematic exploration of its prevalence and full spectrum of protective and risk factors remains limited.
Aims
To investigate the prevalence and factors associated with financial toxicity among patients with cervical cancer.
Design
A cross‐sectional quantitative study.
Methods
We surveyed 351 cervical cancer patients from November 2023 to November 2024 using a general information questionnaire and the patient self‐reported Comprehensive Score for Financial Toxicity. Binary logistic regression identified associated factors.
Results
The 351 participants ranged in age from 25 to 88 years (57.70 ± 11.47 years). The prevalence of financial toxicity was 66.4%. Multivariable analysis demonstrated that each 1‐year increase in age, having commercial insurance and fewer hospitalizations (< 3 times) may be associated with a reduced risk of financial toxicity, whereas lower disposable household savings (< 100,000 CNY), having urban–rural resident basic medical insurance and receiving radiotherapy may be associated with an increased risk.
Conclusions
This study identified factors associated with financial toxicity in cervical cancer patients, with factors associated including age, commercial insurance, basic medical insurance type, disposable household savings, number of hospitalizations and radiotherapy. These findings may assist healthcare providers in identifying patients at higher risk of financial toxicity and inform the development of individualized care plans. Implications for the Profession and/or Patient Care These findings may assist healthcare providers to identify patients who may be at higher risk of financial toxicity early, which may support treatment adherence and health‐related quality of life. Impact This study examined financial toxicity prevalence and associated factors among cervical cancer patients, identified key modifiable and non‐modifiable factors for clinical screening, and may inform nursing practice and healthcare policy adjustments. Reporting Method This study followed the STROBE guidelines for cross‐sectional studies. Patient or Public Contribution No patient or public contribution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Yan'an University, Yan'an, Shaanxi, China.
- The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, China.
- Department of Hematology, Chengdu BOE Hospital, Chengdu, China.
- Medical Oncology, Affiliated Hospital of Yan'an University, Yan'an, Shaanxi, China.
ORCID-Profile: Menghua Wen, Youfu Zhao, Chunying He
Förderung
- Yan'an Science and Technology Development
- Science and Technology Development Research Project of Affiliated Hospital of Yan'an University
- Natural Science Foundation of Shaanxi Province
Zitieren
APA
Li, D., Wen, M., Zhao, Y., Nie, T., Li, M., Yuan, L., Wang, M., Zhu, X., Li, Y., Zhang, Q., & He, C. (2026). Prevalence and Factors Associated With Financial Toxicity in Cervical Cancer Patients: A Cross‐Sectional Study. Nursing Open, 13(10). https://doi.org/10.1002/nop2.70873
Vancouver
Li D, Wen M, Zhao Y, Nie T, Li M, Yuan L, et al. Prevalence and Factors Associated With Financial Toxicity in Cervical Cancer Patients: A Cross‐Sectional Study. Nursing Open. 2026;13(10). doi:10.1002/nop2.70873
BibTeX
@article{Li2026,
author = {Li, Dongliu and Wen, Menghua and Zhao, Youfu and Nie, Tingyu and Li, Miaomiao and Yuan, Li and Wang, Meiming and Zhu, Xiaoyi and Li, Ying and Zhang, Qian and He, Chunying},
title = {Prevalence and Factors Associated With Financial Toxicity in Cervical Cancer Patients: A Cross‐Sectional Study},
journal = {Nursing Open},
year = {2026},
volume = {13},
number = {10},
doi = {10.1002/nop2.70873}
}
EUVIMED